The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Perfluorinated compounds: Emerging POPs with potential immunotoxicity
Open accessAbstract
Perfluorinated compounds (PFCs) have been recognized as an important class of environmental contaminants commonly detected in blood samples of both wildlife and humans. These compounds have been in use for more than 60 years as surface treatment chemicals, polymerization aids, and surfactants. They possess a strong carbon-fluorine bond, which leads to their environmental persistence. There is evidence from both epidemiology and laboratory studies that PFCs may be immunotoxic, affecting both cell-mediated and humoral immunity. Reported effects of PFCs include decreased spleen and thymus weights and cellularity, reduced antibody production, reduced survival after influenza infection, and altered cytokine production. Immunosuppression is a critical effect associated with exposure to PFCs, as it has been reported to reduce antibody responses to vaccination in children. Mounting evidence suggests that immunotoxicity in experimental animals can occur at serum concentrations below, within, or just above the reported range for highly exposed humans and wildlife. Considering bioaccumulation and exposure to multiple PFCs, the risk of immunotoxicity for humans and wildlife cannot be discounted. This review will discuss current and recently published work exploring the immunomodulatory effects of PFCs in experimental animals and humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., & Seed, J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm128 · Cited by 2,620
Olsen, G. W., Burris, J. M., Ehresman, D. J., Froehlich, J. W., Seacat, A. M., Butenhoff, J. L., & Zobel, L. R. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10009 · Cited by 2,049
Chinetti, G., Fruchart, J.-C., & Staels, B. (2000) · Inflammation Research · doi:10.1007/s000110050622 · Cited by 954
The toxicology of perfluorooctanoate
Kennedy, G. L., Butenhoff, J. L., Olsen, G. W., O'Connor, J. C., Seacat, A. M., Perkins, R. G., Biegel, L. B., Murphy, S. R., & Farrar, D. G. (2004) · Critical Reviews in Toxicology · doi:10.1080/10408440490464705 · Cited by 742
Takacs, M. L., & Abbott, B. D. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfl135 · Cited by 396
Granum, B., Haug, L. S., Namork, E., Stølevik, S. B., Thomsen, C., Aaberge, I. S., van Loveren, H., Løvik, M., & Nygaard, U. C. (2013) · Journal of Immunotoxicology · doi:10.3109/1547691x.2012.755580 · Cited by 339
Thirty years of medical surveillance in perfluooctanoic acid production workers
Costa, G., Sartori, S., & Consonni, D. (2009) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0b013e3181965d80 · Cited by 238
Davis, K. L., Aucoin, M. D., Larsen, B. S., Kaiser, M. A., & Hartten, A. S. (2007) · Chemosphere · doi:10.1016/j.chemosphere.2006.11.049 · Cited by 187
Ammonium Perfluorooctanoate Production and Occupational Mortality
Lundin, J. I., Alexander, B. H., Olsen, G. W., & Church, T. R. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181b5f395 · Cited by 156
Post, G. B., Louis, J. B., Cooper, K. R., Boros-Russo, B. J., & Lippincott, R. L. (2009) · Environmental Science & Technology · doi:10.1021/es900301s · Cited by 155
Research works printed but not linked: 66
- Alexander, 2007, Bladder cancer in perfluorooctanesulfonyl fluoride manufacturing workers, Ann. Epidemiol., 17, 471, 10.1016/j.annepidem.2007.01.036 · DOI
- Biegel, 2001, Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats, Toxicol. Sci., 60, 44, 10.1093/toxsci/60.1.44 · DOI · Paper page
- Brieger, 2011, Impact of perfluorooctanesulfonate and perfluorooctanoic acid on human peripheral leukocytes, Toxicol. In Vitro, 25, 960, 10.1016/j.tiv.2011.03.005 · DOI
- Butenhoff, 2004, Characterization of risk for general population exposure to perfluorooctanoate, Regul. Toxicol. Pharmacol., 39, 363, 10.1016/j.yrtph.2004.03.003 · DOI
- Cain, 2010, The relationship between serum uric acid and chronic kidney disease among Appalachian adults, Nephrol. Dial. Transplant., 25, 3593, 10.1093/ndt/gfq262 · DOI
- Calafat, 2006, Human exposure assessment to environmental chemicals using biomonitoring, Int. J. Androl., 29, 166, 10.1111/j.1365-2605.2005.00570.x · DOI
- Calafat, 2007, Serum concentrations of 11 polyfluoroalkyl compounds in the US population: data from the National Health and Nutrition examination survey, Environ. Sci. Technol., 41, 2237, 10.1021/es062686m · DOI · Paper page
- Cheung, 2004, Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor-α, Cancer Res., 64, 3849, 10.1158/0008-5472.CAN-04-0322 · DOI · Paper page
- Corsini, 2011, In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs), Toxicol. Appl. Pharmacol., 250, 108, 10.1016/j.taap.2010.11.004 · DOI
- Corsini, 2012, In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs), Toxicol. Appl. Pharmacol., 258, 248, 10.1016/j.taap.2011.11.004 · DOI · Paper page
- Dewitt, 2008, Perfluorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice, Environ. Health Perspect., 116, 644, 10.1289/ehp.10896 · DOI · Paper page
- DeWitt, 2009, Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha, Crit. Rev. Toxicol., 39, 76, 10.1080/10408440802209804 · DOI · Paper page
- DeWitt, 2009, Suppression of humoral immunity by perfluorooctanoic acid is independent of elevation serum corticosterone concentration in mice, Toxicol. Sci, 109, 106, 10.1093/toxsci/kfp040 · DOI
- DeWitt, 2009, Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha, Crit. Rev. Toxicol., 39, 76, 10.1080/10408440802209804 · DOI · Paper page
- DeWitt, 2012, Immunotoxicity of perfluorinated compounds: recent developments, Toxicol. Pathol., 40, 300, 10.1177/0192623311428473 · DOI · Paper page
- Dietert, 2008, Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment, J. Immunotoxicol., 5, 401, 10.1080/15476910802483324 · DOI
- Domingo, 2012, Health risks of dietary exposure to perfluorinated compounds, Environ. Int., 40, 187, 10.1016/j.envint.2011.08.001 · DOI · Paper page
- Dong, 2011, Sub-chronic effect of perfluorooctanesulfonate (PFOS) on the balance of type 1 and type 2 cytokine in adult C57BL6 mice, Arch. Toxicol., 85, 1235, 10.1007/s00204-011-0661-x · DOI
- EFSA, 2012, Perfluorinated substances in food: occurrence and dietary exposure, EFSA J., 10, 2743, 10.2903/j.efsa.2012.2743 · DOI
- Emmett, 2006, Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters, J. Occup. Environ. Med., 48, 771, 10.1097/01.jom.0000233380.13087.37 · DOI · Paper page
- Eriksen, 2013, Association between plasma PFOA and PFOS levels and total cholesterol in a middle-aged Danish population, PLoS One, 8, e56969, 10.1371/journal.pone.0056969 · DOI · Paper page
- Fair, 2011, Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B6C3F1 mice, J. Immunotoxicol., 8, 17, 10.3109/1547691X.2010.527868 · DOI
- Fang, 2009, Alterations of cytokines and MAPK signaling pathways are related to the immunotoxic effect of perfluorononanoic acid, Toxicol. Sci., 108, 367, 10.1093/toxsci/kfp019 · DOI
- Fei, 2012, Prenatal exposure to PFOA and PFOS and risk of hospitalization for infectious diseases in early childhood, Environ. Res., 110, 773, 10.1016/j.envres.2010.08.004 · DOI
- Germolec, 2004, Sensitivity and predictivity in immunotoxicity testing: immune endpoints and disease resistance, Toxicol. Lett., 149, 109, 10.1016/j.toxlet.2003.12.025 · doi:10.1016/j.toxlet.2003.12.025
- Gilliland, 1993, Mortality among employees of a perfluorooctanoic acid production plant, J. Occup. Med., 35, 950, 10.1097/00043764-199309000-00020 · DOI · Paper page
- Gonzalez, 1998, Mechanism of action of thenon-genotoxic peroxisome proliferators: role of the peroxisome proliferator activator receptor alpha, J. Natl. Cancer Inst., 90, 1702, 10.1093/jnci/90.22.1702 · DOI · Paper page
- Grandjean, 2012, Serum vaccine antibody concentrations in children exposed to perfluorinated compounds, JAMA, 307, 391, 10.1001/jama.2011.2034 · DOI · Paper page
- Guruge, 2009, Effect of perfluorooctane sulfonate (PFOS) on influenza A virus-induced mortality in female B6C3F1 mice, J. Toxicol. Sci., 34, 687, 10.2131/jts.34.687 · DOI
- Holsapple, 2004, Symposium summary: children's health risk–what's so special about the developing immune system?, Toxicol. Appl. Pharmacol., 199, 61, 10.1016/j.taap.2004.03.003 · DOI
- Kato, 2009, Polyfluoroalkyl compounds in pooled sera from children participating in the National Health and Nutrition Examination Survey 2001–2002, Environ. Sci. Technol., 43, 2641, 10.1021/es803156p · DOI
- Lefebvre, 2008, Immunomodulatory effects of dietary potassium perfluorooctane sulfonate (PFOS) exposure in adult Sprague-Dawley rats, J. Toxicol. Environ. Health A, 71, 1516, 10.1080/15287390802391943 · DOI
- Leonard, 2008, Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers, Ann. Epidemiol., 18, 15, 10.1016/j.annepidem.2007.06.011 · DOI · Paper page
- Liu, 1996, The direct effect of hepatic peroxisome proliferators on rat Leydig cell function in vitro, Fundam. Appl. Toxicol., 30, 102, 10.1006/faat.1996.0047 · DOI
- Liu, 1996, Effect of the peroxisome proliferator, ammonium perfluorooctanoate (C8), on hepatic aromatase activity in adult male Crl:CDBR (CD) rats, Fundam. Appl. Toxicol., 30, 220, 10.1006/faat.1996.0059 · DOI
- Loveless, 2008, Evaluation of the immune system in rats and mice administered linear ammonium perfluorooctanoate (APFO), Toxicol. Sci., 105, 86, 10.1093/toxsci/kfn113 · DOI
- Luster, 1992, Risk assessment in immunotoxicology: I. Sensitivity and predictability of immune tests, Fundam. Appl. Toxicol., 18, 200, 10.1016/0272-0590(92)90047-L · DOI · Paper page
- Luster, 2005, Biomarkers to assess potential developmental immunotoxicity in children, Toxicol. Appl. Pharmacol., 206, 229, 10.1016/j.taap.2005.02.010 · DOI
- Luster, 1993, Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests, Fundam. Appl. Toxicol., 21, 71, 10.1006/faat.1993.1074 · DOI · Paper page
- Okada, 2012, Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants, Environ. Res., 112, 118, 10.1016/j.envres.2011.10.003 · DOI
- Olsen, 1999, Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees, J. Occup. Environ. Med., 41, 799, 10.1097/00043764-199909000-00012 · DOI · Paper page
- Palmer, 1998, Peroxisome proliferator activated receptor-alpha expression in human liver, Mol. Pharmacol., 53, 14, 10.1124/mol.53.1.14 · DOI · Paper page
- Pastoor, 1987, Biochemical and morphological studies of ammonium perfluorooctanoate-induced hepatomegaly and peroxisome proliferation, Exp. Mol. Pathol., 47, 98, 10.1016/0014-4800(87)90011-6 · DOI
- Peden-Adams, 2009, Health effects of perfluorinated compounds—what are the wildlife telling us?, Reprod. Toxicol., 27, 414, 10.1016/j.reprotox.2008.11.016 · DOI
- Peden-Adams, 2007, Suppression of humoral immunity following exposure to the perfluorinated insecticide sulfluramid, J. Toxicol. Environ. Health A, 70, 1130, 10.1080/15287390701252733 · DOI
- Peden-Adams, 2008, Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate, Toxicol. Sci., 104, 144, 10.1093/toxsci/kfn059 · DOI · Paper page
- Peden-Adams, 2010, Effects of perfluorooctanesulfonic acid (PFOS) on NF-kB, AP-1, and PPAR-alpha, Toxicologist, 114, 330
- Peraza, 2006, The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR), Toxicol. Sci., 90, 269, 10.1093/toxsci/kfj062 · DOI · Paper page
- Qazi, 2010, Toxicology, 267, 132, 10.1016/j.tox.2009.10.035 · DOI
- Rayne, 2009, Perfluoroalkyl sulfonic and carboxylic acids: a critical review of physicochemical properties, levels and patterns in waters and wastewaters, and treatment methods, J. Environ. Sci. Health A Tox. Hazard Subst. Environ. Eng., 44, 1145, 10.1080/10934520903139811 · DOI · Paper page
- Saccani, 2002, p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment, Nat. Immunol., 3, 69, 10.1038/ni748 · DOI · Paper page
- Schmitz, 2001, I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations, Trends Biochem. Sci., 26, 186, 10.1016/S0968-0004(00)01753-9 · DOI · Paper page
- Steenland, 2010, Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA), Environ. Health Perspect., 118, 1100, 10.1289/ehp.0901827 · DOI · Paper page
- Suja, 2009, Contamination, bioaccumulation and toxic effects of perfluorinated chemicals (PFCs) in the water environment: a review paper, Water Sci. Technol., 60, 1533, 10.2166/wst.2009.504 · DOI · Paper page
- Ubel, 1980, Health status of plant workers exposed to fluorochemicals–a preliminary report, Am. Ind. Hyg. Assoc. J., 41, 584, 10.1080/15298668091425310 · DOI
- Vermeulen, 2002, Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit, Biochem. Pharmacol., 64, 963, 10.1016/S0006-2952(02)01161-9 · DOI · Paper page
- Vermeulen, 2003, Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1), EMBO J., 22, 1313, 10.1093/emboj/cdg139 · DOI · Paper page
- van Loveren, 1999, Report of the Bilthoven symposium: advancement of epidemiological studies in assessing the human health effects of immunotoxic agents in the environment and the workplace, Biomarkers, 4, 135, 10.1080/135475099230949 · DOI
- Vestergren, 2009, Tracking the pathways of human exposure to perfluorocarboxylates, Environ. Sci. Technol., 43, 5565, 10.1021/es900228k · DOI · Paper page
- Yang, 2000, Effects of peroxisome proliferators on the thymus and spleen of mice, Clin. Exp. Immunol., 122, 219, 10.1046/j.1365-2249.2000.01367.x · DOI
- Yang, 2001, Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice, Biochem. Pharmacol., 62, 1133, 10.1016/S0006-2952(01)00752-3 · DOI
- Yang, 2002, Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferators perfluorooctanoic acid, Int. Immunopharmacol., 2, 389, 10.1016/S1567-5769(01)00164-3 · DOI · Paper page
- Wang, 2011, The effect of prenatal perfluorinated chemicals exposures on pediatric atopy, Environ. Res., 111, 785, 10.1016/j.envres.2011.04.006 · DOI
- Weihe, 2008, Serum concentrations of polyfluoroalkyl compounds in Faroese whale meat consumers, Environ. Sci. Technol., 42, 6219, 10.1021/es800695m · DOI
- Zareitalabad, 2013, Perfluorooctanoic acid (PFOA) and perfluoroocanesulfonic acid (PFOS) in surface waters, sediments, soils and wastewater–a reveiw on concentrations and distributions coefficients, Chemosphere, 91, 725, 10.1016/j.chemosphere.2013.02.024 · DOI · Paper page
- Zheng, 2011, Type 1 and Type 2 cytokines imbalance in adult male C57BL/6 mice following a 7-day oral exposure to perfluorooctanesulfonate (PFOS), J. Immunotoxicol., 8, 30, 10.3109/1547691X.2010.537287 · DOI
Cited by
Kurwadkar, S., Dane, J., Kanel, S. R., Nadagouda, M. N., Cawdrey, R. W., Ambade, B., Struckhoff, G. C., & Wilkin, R. (2022) · Science of The Total Environment · doi:10.1016/j.scitotenv.2021.151003 · Cited by 937
Emerging contaminants of high concern for the environment: Current trends and future research
Khan, S., Naushad, M., Govarthanan, M., Iqbal, J., & Alfadul, S. M. (2022) · Environmental Research · doi:10.1016/j.envres.2021.112609 · Cited by 724
Comparing the toxic potency in vivo of long-chain perfluoroalkyl acids and fluorinated alternatives
Gomis, M. I., Vestergren, R., Borg, D., & Cousins, I. T. (2018) · Environment International · doi:10.1016/j.envint.2018.01.011 · Cited by 438
Immunotoxic effects of environmental pollutants in marine mammals
Desforges, J.-P. W., Sonne, C., Levin, M., Siebert, U., De Guise, S., & Dietz, R. (2016) · Environment International · doi:10.1016/j.envint.2015.10.007 · Cited by 411
Sharma, B. M., Bharat, G. K., Tayal, S., Larssen, T., Bečanová, J., Karásková, P., Whitehead, P. G., Futter, M. N., Butterfield, D., & Nizzetto, L. (2016) · Environmental Pollution · doi:10.1016/j.envpol.2015.10.050 · Cited by 353
Metadata
- Authors
- Corsini, E., Luebke, R. W., Germolec, D. R., & DeWitt, J. C.
- Venue
- Toxicology Letters
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 230
- Issue
- 2
- Pages
- 263-270
- ISSN
- 0378-4274 (ISSN-L)
- OpenAlex
- W2001939379
- Cited by
- 206
- References
- 12
- FWCI
- 9.97
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Perfluorinated compounds: Emerging POPs with potential immunotoxicity. https://app.cochat.ai/papers/10.1016/j.toxlet.2014.01.038
- The paper
- Corsini, E., Luebke, R. W., Germolec, D. R., & DeWitt, J. C. (2014). Perfluorinated compounds: Emerging POPs with potential immunotoxicity. Toxicology Letters. https://doi.org/10.1016/j.toxlet.2014.01.038
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.